A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) ...
Legit.ng on MSN
Graduate of University of Ibadan shares what she did that made her bag first‑class, goes viral
A graduate of the University of Ibadan inspires many as she shares what she did in 300‑level that made her finish from the ...
Legit.ng on MSN
University of Ibadan law graduate who initially showed no interest in her course bags first class
A University of Ibadan law graduate celebrated earning a first-class degree despite not initially being interested. She shared her passion for sports law.
Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...
Pfizer ( PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed ...
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...
Despite being confident about his preparation, Anirudh did not anticipate securing a top 3 rank. That is why seeing AIR 2 ...
What happens when you focus on the things that truly matter and strip away the things that don’t?” the president said.
MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results